Literature DB >> 7862885

mu-Opioid receptor and alpha 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts.

A M Gabilondo1, J J Meana, F Barturen, M Sastre, J A García-Sevilla.   

Abstract

The biochemical status of human brain mu-opioid receptors and alpha 2-adrenoceptors during opiate dependence was studied by means of the binding of [3H] [D-Ala2, MePhe4, Gly-ol5] enkephalin (DAGO) and [3H]clonidine, respectively, in postmortem brains of heroin addicts who had died by opiate overdose or other causes. In the frontal cortex, thalamus and caudate of heroin addicts the density (Bmax) and affinity (KD) of mu-opioid receptors were similar to those in controls. In contrast, the density of alpha 2-adrenoceptors in heroin addicts was found to be significantly decreased in frontal cortex (Bmax 31% lower), hypothalamus (Bmax 40% lower) and caudate (Bmax 32% lower) without changes in KD values. When heroin addicts were divided into two subgroups according to the presence or absence of morphine in body fluids, only the group with positive screening for morphine showed relevant decreases in brain alpha 2-adrenoceptor density (Bmax 36-48% lower), whereas the decreases in receptor density observed in the subgroup with negative screening for morphine did not reach statistical significance. The results suggest that desensitization of brain alpha 2A-adrenceptors is a relevant adaptative receptor mechanism during opiate addiction in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862885     DOI: 10.1007/bf02244763

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.

Authors:  B J Van Vliet; T J De Vries; G Wardeh; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1991-10-14       Impact factor: 4.432

Review 2.  Common alpha 2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices.

Authors:  G K Aghajanian; Y Y Wang
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

3.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

4.  Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

5.  Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.

Authors:  R S Duman; J F Tallman; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

6.  Selective changes in mu opioid receptor properties induced by chronic morphine exposure.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  The role of opioid receptor density in morphine tolerance.

Authors:  K Lutfy; B C Yoburn
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

8.  Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.

Authors:  D S Charney; D E Redmond; M P Galloway; H D Kleber; G R Heninger; M Murberg; R H Roth
Journal:  Life Sci       Date:  1984-09-17       Impact factor: 5.037

9.  Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.

Authors:  I Ulibarri; J A García-Sevilla; L Ugedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

10.  Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex.

Authors:  M Raiteri; G Bonanno; G Maura; M Pende; G C Andrioli; A Ruelle
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more
  7 in total

1.  The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis.

Authors:  Paige J Baugher; Ann Richmond
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

Review 2.  Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.

Authors:  Laura Albizu; José L Moreno; Javier González-Maeso; Stuart C Sealfon
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

Review 3.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

4.  Acute effects of morphine on distinct forms of impulsive behavior in rats.

Authors:  Tommy Pattij; Dustin Schetters; Mieke C W Janssen; Joost Wiskerke; Anton N M Schoffelmeer
Journal:  Psychopharmacology (Berl)       Date:  2009-05-13       Impact factor: 4.530

Review 5.  GPCR oligomers in pharmacology and signaling.

Authors:  Javier González-Maeso
Journal:  Mol Brain       Date:  2011-05-27       Impact factor: 4.041

Review 6.  The neuropsychology of amphetamine and opiate dependence: implications for treatment.

Authors:  Karen D Ersche; Barbara J Sahakian
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

7.  Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study.

Authors:  Elizabeth Scarr; Tammie Terese Money; Geoffrey Pavey; Jaclyn Neo; Brian Dean
Journal:  BMC Psychiatry       Date:  2012-08-28       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.